Hosted on MSN33m
AnaptysBio initiated with an Outperform at Wolfe ResearchWolfe Research analyst Andy Chen initiated coverage of AnaptysBio (ANAB) with an Outperform rating and $25 price target The stock’s current ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback